tradingkey.logo

Imunon Inc

IMNN

4.980USD

-0.120-2.35%
收盘 09/19, 16:00美东报价延迟15分钟
9.84M总市值
亏损市盈率 TTM

Imunon Inc

4.980

-0.120-2.35%
关于 Imunon Inc 公司
Imunon, Inc. 是一家临床阶段的生物技术公司。该公司专注于开发一系列利用人体自然机制治疗一系列人类疾病的治疗方法。该公司正在开发四种模式的非病毒脱氧核糖核酸 (DNA) 技术。第一种模式 TheraPlas 是为治疗实体瘤而开发的蛋白质和细胞因子编码。第二种模式 PlaCCine 是为编码可引发强烈免疫反应的病毒抗原而开发的。第三种模式 FixPlas 涉及应用 Imunon 的 DNA 技术生产通用癌症疫苗,也称为肿瘤相关抗原癌症疫苗。第四种模式 IndiPlas 处于发现阶段,专注于开发个性化癌症疫苗或新表位癌症疫苗。其主要临床项目 IMNN-001 是一种基于 DNA 的免疫疗法,用于局部治疗晚期卵巢癌。
公司简介
公司代码IMNN
公司名称Imunon Inc
上市日期Oct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
员工数量25
证券类型Ordinary Share
年结日Oct 27
公司地址997 Lenox Dr Ste 100
城市LAWRENCEVILLE
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编08648
电话16098969100
网址https://imunon.com/
公司代码IMNN
上市日期Oct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
5.65K
+6.60%
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
4.54K
+402.99%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
4.31K
+119.57%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.82K
+77.50%
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
3.82K
--
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
3.42K
+246.55%
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Independent Director
Independent Director
2.58K
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
5.65K
+6.60%
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
4.54K
+402.99%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
4.31K
+119.57%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.82K
+77.50%
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
3.82K
--
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
3.42K
+246.55%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
Sabby Management, LLC
3.15%
Renaissance Technologies LLC
2.23%
The Vanguard Group, Inc.
0.67%
Geode Capital Management, L.L.C.
0.51%
Tardugno (Michael H)
0.26%
其他
93.19%
持股股东
持股股东
占比
Sabby Management, LLC
3.15%
Renaissance Technologies LLC
2.23%
The Vanguard Group, Inc.
0.67%
Geode Capital Management, L.L.C.
0.51%
Tardugno (Michael H)
0.26%
其他
93.19%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
3.88%
Hedge Fund
2.40%
Individual Investor
1.48%
Investment Advisor
0.94%
Research Firm
0.39%
Venture Capital
0.10%
Bank and Trust
0.03%
其他
90.78%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
52
152.78K
6.20%
-44.01K
2025Q1
50
565.85K
3.09%
-1.96M
2024Q4
52
608.75K
4.16%
-1.78M
2024Q3
50
1.20M
8.34%
-536.74K
2024Q2
48
484.50K
4.81%
-359.07K
2024Q1
49
447.12K
4.68%
-585.60K
2023Q4
59
755.78K
7.96%
-79.04K
2023Q3
65
452.55K
4.85%
-471.22K
2023Q2
68
440.18K
4.85%
-489.81K
2023Q1
80
515.97K
6.03%
-572.90K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Renaissance Technologies LLC
10.44K
0.05%
-23.12K
-68.89%
Mar 31, 2025
The Vanguard Group, Inc.
48.81K
0.23%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
143.44K
0.67%
+3.93K
+2.82%
Mar 31, 2025
Tardugno (Michael H)
73.71K
0.35%
+4.57K
+6.61%
May 13, 2025
Fritz (Frederick J)
11.77K
0.06%
--
--
May 13, 2025
BlackRock Institutional Trust Company, N.A.
58.22K
0.27%
--
--
Mar 31, 2025
Braun (Donald P)
25.60K
0.12%
--
--
May 13, 2025
Le (Goff Corinne)
53.00K
0.25%
--
--
May 13, 2025
Lindborg (Stacy R)
28.06K
0.13%
--
--
May 13, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
公告日期
类型
比率
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
Feb 28, 2022
Merger
15→1
KeyAI